Seth Ettenberg, Chief Scientific Officer at Unum Therapeutics Inc. (UMRX), sold 22,970 shares at $8.46 ($194K) on 2018-10-25, disclosed to the SEC on 2018-10-29.
Open-market sale of $194k UMRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 11,485 | $97K | 50.0% |
| 2 | $8.46 | 11,485 | $97K | 50.0% |
| Total | $8.46 avg | 22,970 | $194K | 100% |
| Filing → |
| UMRX | SELL | 2018-12-28 | $47K | — | Filing → |
| UMRX | SELL | 2018-11-26 | $80K | — | Filing → |
| UMRX | SELL | 2018-09-26 | $286K | — | Filing → |